Alpha Fetoprotein, Total and L3 Percent
0081208
 
Ordering Recommendation
Surveillance and monitoring of hepatocellular carcinoma.
Mnemonic
AFP L3
Methodology
Quantitative Liquid Chromatography/Immunoassay
Performed
Mon,Thu
Reported
1-5 days
New York DOH Approval Status
This test is New York DOH approved.
Specimen Required
Patient Preparation
 
Collect
Serum separator tube.  
Specimen Preparation
Allow specimen to clot completely at room temperature. Separate serum from cells ASAP or within 2 hours of collection. Transfer 1 mL serum to an ARUP Standard Transport Tube. (Min: 0.5 mL)  
Storage/Transport Temperature
Frozen.  
Unacceptable Conditions
Plasma.  
Remarks
 
Stability
After separation from cells: Ambient: 8 hours; Refrigerated: 5 days; Frozen: 3 months (avoid repeated freeze/thaw cycles)  
Reference Interval
By report
Test Number Components Reference Interval
Alpha Fetoprotein Total 0-​15 ng/mL
Alpha Fetoprotein L3 Percent 0-​9.9 percent
Interpretive Data
The µTASWako method is used. Results obtained with different assay methods or kits cannot be used interchangeably. The AFP L3 Percent assay is intended as a risk assessment for the development of hepatocellular carcinoma in patients with chronic liver diseases. Patients with elevated serum AFP-L3 percent should be more intensely evaluated for evidence of hepatocellular carcinoma since elevated values have been shown to be associated with a seven-fold increase in the risk for developing hepatocellular carcinoma within 21 months. For pregnant females, the result is not interpretable as a tumor marker.
Note
CPT Code(s)
82107
Components
Component Test Code*Component Chart Name
0081207Alpha Fetoprotein Total
0081209Alpha Fetoprotein L3 Pct
* Component test codes cannot be used to order tests. The information provided here is not sufficient for interface builds; for a complete test mix, contact interface support at interface.support@aruplab.com.
Cross References
  • AFP
  • AFP-L3%
  • Alpha Fetoprotein
  • Alpha Fetoprotein, Total and L3 Percent
  • Alpha-Fetoprotein (AFP) L3% and Total, Hepatocellular Carcinoma Tumor Marker, Serum
  • Alpha-fetoprotein, Total
  • Hepatocellular Carcinoma AFP
  • Total AFP